A novel infl ammatory marker in clinical practice
We intentionally read the article "Red cell distribution width is associated with acute myocardial infarction in young patients" written by Uysal et al. with great interest [1] . They aimed to investigate the relationship between red cell distribution width (RDW) and acute ST-elevated myocardial infarction (STEMI) in young patients. Compared with young patients with normal coronaries, young patients with STEMI had signifi cantly higher values of RDW. Higher levels of RDW was an independent predictor of STEMI in young patients together with gender, history of hyperlipidemia. The study is successfully designed and presented. We believe that these fi ndings will elucidate further studies about RDW as a surrogate marker of infl ammation and atherosclerosis. Thank to the authors for their contribution.
RDW, a measurement of variability and size of erythrocytes, can be easily measured during routine complete blood counts [2] . Increased RDW, independent of hemoglobin values, has been demonstrated to be associated with negative clinical outcomes in patients with heart failure, previous myocardial infarction, and stable coronary artery disease [3] . The association of RDW with adverse outcomes in cardiovascular diseases has not been fully understood. Infl ammation may cause changes in red blood cell maturation by disturbing the red cell membrane, leading to increased RDW.
The pathogenesis of atherosclerosis is multifactorial; however, it is considered to be an infl ammatory disease [4] . Previous studies have demonstrated that elevated levels of infl ammatory molecules are markers of atherosclerotic disease activity and also indicate an increased risk for the progression of atherosclerosis. So, there is a signifi cant relationship between the endothelial dysfunction, and inflammatory parameters and cardiovascular risk factors such as hypertension, diabetes mellitus, smoking and hypercholesterolemia [5] . Because these factors may affect the levels of RDW, compared to patient groups, control groups should be similar in features according to risk factors and in terms of the number of the individuals. If we see an increased RDW level in a patient, we do think that there is a problem about hematologic parameters or the patients may have some of these diseases. Although it is an easy method to assess infl ammation and it may be useful in clinical practice, RDW itself alone without other infl ammatory markers may not give information to clinicians about the endothelial infl ammatory condition of the patient. So, we think that it should be evaluated together with other serum infl ammatory markers.
In addition, the authors are required to give information about the selection of patients in the control group. Finally, all measurements were performed 30 min after blood collection in this study. They should defi ne why they measured after 30 min because 30 min delay after blood sampling can cause abnormal results in RDW measurement. In addition, these patients are expected to have higher infl ammatory marker levels compared to healthy populations. Further studies should be made to enlighten the role of RDW as an inflammatory marker in atherosclerotic disease subjects.
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